PubMed چکیده/رکورد

Expanding CAM Models: In Vivo PET/CT Imaging of Cancer Xenografts on the Ostrich CAM.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Animal models are utilized in the investigation of a variety of research questions in nuclear medicine. Radiopharmaceutics are usually tested in mouse, rat or chick chorioallantoic membrane (CAM) models and visualisation of their biodistribution is performed using dedicated small-animal PET/CT scanners. However, the limited availability of such scanners represents a significant bottleneck in preclinical imaging. To address this limitation, we explored an alternative animal model compatible with clinical imaging systems. The ostrich chorioallantoic membrane (CAM) was utilized as a platform for tumor xenografts, enabling imaging with a standard human PET/CT scanner. Growth conditions for tumor formation were established using human glioblastoma (U87) and breast cancer (MDA-MB-231) cell lines. Tumor visualization was achieved using 18F-fluorodeoxyglucose (18F-FDG), a widely used clinical PET tracer, and its pharmacodynamic behavior was assessed. Our findings demonstrate that the ostrich CAM tumor model is a feasible and efficient system for the rapid evaluation of diagnostic tracers. Importantly, tracer uptake and kinetics can be reliably assessed using a clinical PET/CT scanner. This approach highlights the potential of the ostrich embryonic model as a versatile and accessible preclinical platform for nuclear medicine research.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

FDGMDA-MB-231Ostrich CAM ModelPET/CT ImagingU87Xenograftingalternative animal modelcancer research
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Comprehensive Approach to Prostate Cancer Metastasis Mimics at Prostate-Specific Membrane Antigen PET/CT.

Prostate-specific membrane antigen (PSMA) PET has transformed prostate cancer (PCa) imaging. Nevertheless, major diagnostic pitfalls remain as PSMA expression is not exclusive to PCa and may also occur in physiologic tissues and a range of benign and malignant conditions. These conditions may mimic PCa metastases, leading to potential misinterpretation. Accurate risk assessment of suspected lesions using PSMA PET/CT requires the integr…

PubMed2026

Preoperative porta hepatis-to-hepatic surface ratio on 24-h delayed hepatobiliary scintigraphy is associated with jaundice clearance after Kasai portoenterostomy.

PURPOSE: Biliary atresia (BA) often requires liver transplantation despite Kasai portoenterostomy (KPE). The prognostic role of hepatobiliary scintigraphy remains unclear. METHODS: Twenty-three infants undergoing KPE between 2017 and 2024 were retrospectively analyzed. Patients without 6-h bowel activity on technetium-99 m PMT hepatobiliary scintigraphy underwent 24-h delayed imaging. The primary endpoint was jaundice clearance (total …

PubMed2026

Cost-effectiveness of ferumoxtran-enhanced macrophage-specific-MRI and PSMA-PET/CT versus ePLND for nodal staging in primary prostate cancer: a decision analysis based on updated phase-3 trial data.

BACKGROUND AND OBJECTIVE: Accurate nodal staging in intermediate- to high-risk prostate cancer (PCa) is crucial for treatment decisions. While extended pelvic lymph node dissection (ePLND) is the standard, it is invasive and has a low diagnostic yield. A 2019 analysis suggested that non-invasive imaging such as PSMA-PET/CT and ferumoxtran-enhanced macrophage-MRI (m-MRI) is cost-effective, but at the possible expense of a small QALY los…

PubMed2026

Dual Dopaminergic and Limbic-Cognitive Contributions to Gait Parameters in De Novo Parkinson Disease.

BACKGROUND AND OBJECTIVES: Parkinson disease (PD) is a progressive neurodegenerative disease in which gait impairment is a common and disabling clinical feature. We aimed to characterize the independent and mediated contributions of striatal dopamine transporter (DAT) availability and gray matter (GM) volume to quantitative gait impairment in de novo PD. METHODS: In this prospective study, we consecutively recruited patients with de no…